COST
58
-2
CINF
47
2
ICE
59
-3
ZTS
47
2
AMP
69
-3
DVA
72
2
AXP
66
2
ETR
68
3
TGNA
53
2
HCP
58
4
HOG
29
-4
PX
75
5
TDC
75
4
SWK
56
-2
DTE
50
3
HSIC
54
-3
EXC
54
-2
DAL
80
-4
F
43
-8
MS
74
-2
COST
58
-2
CINF
47
2
ICE
59
-3
ZTS
47
2
AMP
69
-3
DVA
72
2
AXP
66
2
ETR
68
3
TGNA
53
2
HCP
58
4
HOG
29
-4
PX
75
5
TDC
75
4
SWK
56
-2
DTE
50
3
HSIC
54
-3
EXC
54
-2
DAL
80
-4
F
43
-8
MS
74
-2
Financhill
Back

Molecular Partners AG 10K Form

Sell
21

MOLN
Molecular Partners AG

Last Price:
5.34
Seasonality Move:
28.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MOLN News And Ratings

See the #1 stock for the next 7 days that we like better than MOLN

MOLN Financial Statistics

Sales & Book Value

Annual Sales: $7.84M
Cash Flow: $-17.34M
Price / Cash Flow: 0
Annual Sales: $4.97
Price / Book: 1.3

Profitability

EPS (TTM): -2.14130
Net Income (TTM): $-70.92M
Gross Margin: --
Return on Equity: -37.36%
Return on Assets: -33.67%

Molecular Partners AG Earnings Forecast

Key Molecular Partners AG Financial Ratios

  • The Research & Development expenses have been 693.15% of Revenue.
  • The Interest Expense is -0.05% of Operating Income.
  • The Net Earning history of MOLN is -880.71% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Molecular Partners AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MOLN
Website: molecularpartners.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.33
Quick Ratio: 14.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MOLN Technical Analysis vs Fundamental Analysis

Sell
21
Molecular Partners AG (MOLN) is a Sell

Is Molecular Partners AG a Buy or a Sell?